New Key Statistics Module, Z-Score and F-Score
NAS:TCRT Key Ratios
Market Cap $ M | 3.52 |
Enterprise Value $ M | -2.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.93 |
Price/Sales | 550.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -12.71 |
Beneish M-Score | 389.79 |
10-y EBITDA Growth Rate % | -5.90 |
5-y EBITDA Growth Rate % | -48.10 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.11 |
EV-to-EBITDA | 0.11 |
PEG | -- |
Shares Outstanding M | 1.60 |
Net Margin (%) | -318,833.33 |
Operating Margin % | -225,033.33 |
Pre-tax Margin (%) | -318,833.33 |
Quick Ratio | 5.16 |
Current Ratio | 5.16 |
ROA % (ttm) | -144.17 |
ROE % (ttm) | -189.69 |
ROIC % (ttm) | -362.68 |
Dividend Yield % | -- |
Altman Z-Score | -284.75 |
TCRT Number of Guru Trades
TCRT Volume of Guru Trades
Gurus Latest Trades with NAS:TCRT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alaunos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRT
Total 0- 1